Skip to Main Content

Paper Details

Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.
Cell Rep
141
2016
Cancers, Human, Human Cancers, KEAP1, KEAP1 interaction domain, NFE2L2 Exon 2, NFE2L2 gene, Nrf2, Nrf2 protein isoforms, cancers, cell-line-derived gene signature, exon 2, exons 2, human, human tumors, oncogenes, splice variants, transcript variants, tumors
Author NameAffiliation
Robert GentlemanGenentech Inc.
Robert GentlemanGenentech Inc.
  • 1 - 2

Datasets

Release 1.2